Graviton
Rochester Hills, MI
Graviton develops novel therapeutics for the treatment of autoimmune, cancer, certain genetic, fibrotic, and other serious diseases. TDI01, a highly selective, potent inhibitor of Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2) is currently being studied in the United States for the treatment of idiopathic pulmonary fibrosis (IPF). Graviton anticipates entering human clinical studies in the U.S. in 2021.
graviton.bioCompany Details
Founded
- 2020
Employees
- Between 50 - 100 employees
Raised
- Unknown
Headquarters Location
- Rochester Hills, MI
Public
- No
Acquired
- No
Company Collections
These are collections Graviton is a part of. Click on the collection name to view similar companies.
Graviton's Tech Stack
Graviton's Industries
Graviton Headquarters Location
Rochester Hills, MI 48309
Graviton Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Graviton.